Nektar(NKTR) - 2025 FY - Earnings Call Transcript
Nektar Therapeutics (NKTR) FY 2025 Conference May 20, 2025 01:30 PM ET Speaker0 Sorry. Good afternoon, everyone. My name is right now, Respag definitely the topic for Nektar. But before we dive into the real business, I'm just curious. So could you give us a quick overview of the Respag history? How did it translate from a collaborative program with Lilly in back to your hands? Speaker1 Sure. Yeah. So we invented Respag, aldesleukin, which uses the I l two protein sequence, and it's the native sequence with ...